Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Paul Rhomberg, BS, MT(ASCP)
Drug Development Manager
JMI Laboratories
Poster(s):
(568) Evaluation of the VITEK 2 XL Antimicrobial Susceptibility Testing for Non-fermenter Gram-Negative Bacilli: The Importance of Continuing to Monitor AST Systems
Thursday, October 12, 2023
12:15 PM – 1:30 PM
US ET
(2113) Evaluation of Isavuconazole Activity against
Aspergillus fumigatus
Causing Invasive Infections Worldwide Using the New CLSI Clinical Breakpoints
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2114) Evaluation of Isavuconazole Activity against Non-
fumigatus
Aspergillus
and cryptic
Aspergillus
species Causing Invasive Infections Worldwide
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2115) Rezafungin Activity against Invasive Candidiasis Isolates Globally: Results from the 2022 Rezafungin Surveillance Program
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
